Even with the success of reducing smoking, lung cancer remains the leading cause of cancer deaths worldwide for both men and women. In 2023, there were approximately 238,000 new lung cancers and 125,000 deaths in the United States alone. In recent decades, the evolution of roboticassisted thoracic surgery has enhanced primary lung cancer treatment and postoperative outcomes. This, in combination with advances in immunotherapy and our understanding of cancer’s molecular biology, brings many tools to the battle against the leading cause of cancer deaths in the United States.

Join Dr. Mark Dylewski, chief of general thoracic surgery at Baptist Health, and Dr. Paul Kaywin, medical oncologist at Baptist Health Miami Cancer Institute, as they discuss advances in lung cancer treatment from a medical oncology and surgical perspective.


Mark Dylewski, M.D.
Director of General Thoracic Surgery and Robotic Thoracic Surgery
Chief of General Thoracic Surgery, Baptist Health
Chairman of Thoracic Surgical Oncology, Miami Cancer Institute

Paul Kaywin, M.D.
Medical Oncologist
Miami Cancer Institute
Baptist Health

#lungcancer
#lungcancerawareness
#lungcancertreatment
#thoracicsurgery

0:00 Introduction
2:10 A Multidisciplinary Approach
3:59 Treating Lung Cancer Patients as Individuals
7:12 Advancements in Thoracic Surgery
13:12 Treating the Different Stages of Lung Cancer
16:57 Lung Cancer Screenings
21:05 Future Advancements in Surgical Treatment
23:42 Future of Clinical Trials in Treating Lung Cancer